ClinicalTrials.gg
RecruitingNCT07937098Updated Nov 13, 2026

Effects of Instrument-Assisted Soft Tissue Mobilization (IASTM) Along With Conventional Physical Therapy on Upper Limb Function, Strength, Range of Motion, and Spasticity in Patients With Subacute Stroke.

An interventional study of IASTM + Conventional Physical Therapy and Conventional Physical Therapy in Stroke, sponsored by Ibadat International University, Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Ibadat International University, Islamabad · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2026, registered Nov 2026).
  • Started Jul 2026; still recruiting 4 months later.
Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 333 studies in Stroke with a site in Pakistan — 103 open to participants now, 134 under way, 1 of them phase 3. Stroke · Pakistan.

Planned enrollment
132nd of 306
46 · median 42
Started
2026
with 52 others
No phase
300 of 333
99 open now
Primary completion
2026-11
later than 115 of 133 live
Registered
331st of 333
by date
Lead sponsor
7 of 333
Ibadat International University, Islamabad

Among the 333 studies in Stroke with a site in Pakistan, this one is the 132nd largest by planned enrollment of the 306 interventional ones that give a count, is one of 53 that started in 2026, is one of 300 with no phase, reaches primary completion later than 115 of the 133 other live ones, and was the 331st registered.

Stroke

8,269 studies on the registry are indexed under Stroke; 2,062 are open to participants now.

Browse Stroke studies →

Open to participants now

103 of the 333 studies in Stroke with a site in Pakistan are open now. Recruiting first, the newest first:

97 more — sign in →

All 103 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 696 (49%) set no upper age limit and 282 (20%) stop at 75 or younger; 77 take children under 18; 196 take healthy volunteers.

This study: 40 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 333 studies in Stroke with a site in Pakistan, or all of them as a file.
02

Study summary

This randomized controlled trial aims to compare the effects of IASTM (Instrument-Assisted Soft Tissue Mobilization) along with conventional physical therapy on function, strength, range of motion, and spasticity of the upper limb in patients with subacute stroke.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • stroke
  • instrument assissted soft tissue mobilization
  • conventional physical therapy
  • strength
04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • First-ever stroke (ischemic or hemorrhagic) diagnosed via CT/MRI
  • Subacute stage (2 weeks to 6 months post-stroke)
  • Age 40-60 years
  • Upper limb hemiparesis with Modified Ashworth Scale score 2 and 3
  • (Mini-Mental State Examination) score ≥ 24
  • Capable of follow simple verbal commands

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment affecting the ability to follow instructions.
  • Recurrent stroke
  • Presence of other neurological disorders such as Parkinson's disease or multiple sclerosis etc.
  • Recent upper limb surgery, fractures or musculoskeletal injury affecting the arm or hand.
  • Fixed contracture of upper limb joints
  • Severe aphasia or inability to follow commands
  • Uncontrolled diabetes mellitus, hypertension
  • Serious cardiac problems or unstable cardiovascular disease
  • Skin conditions, open wounds, or infections affecting upper limb
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Group A: IASTM + Conventional Physical Therapy

    IASTM + Conventional Physical Therapy

    Other: IASTM + Conventional Physical Therapy

  • Active comparator
    Group B: Conventional Physical Therapy

    Conventional Physical Therapy

    Other: Conventional Physical Therapy

Interventions

  • OtherIASTM + Conventional Physical Therapy

    5-10 minutes per session applied to affected upper limb muscles (biceps brachii, brachialis, flexor carpi radialis, flexor carpi ulnaris, thenar and hypothenar muscles) using stainless steel instruments * Technique: Multidirectional strokes at 30-60 second intervals * Intensity: Moderate pressure causing mild erythema without bruising * Frequency: 3 sessions/week for 6 weeks * Conservative Physical Therapy: 45-minute session including * Passive stretching of spastic muscles (15 min) * Active-assisted ROM exercises (10 min) * Strengthening exercises (10 min) - including isometric holds, concentric/eccentric contractions as tolerated * Task-oriented Training of upper limb, {Reaching activities, Grasping \& releasing objects, Object manipulation tasks (stacking blocks, turning objects), Simulated ADL tasks (feeding, grooming) (10 min)}

  • OtherConventional Physical Therapy

    45-minute session. * Passive stretching of spastic muscles (15 min) * Active-assisted ROM exercises (10 min) * Strengthening exercises (10 min)-including isometric holds and concentric/eccentric contractions as tolerated * Task-oriented Training of upper limb, {Reaching activities, Grasping \& releasing objects, Object manipulation tasks (stacking blocks, turning objects), Simulated ADL tasks (feeding, grooming)} (10 min)

06

What researchers measure

Primary outcomes

  1. Modified Ashworth Scale (MAS)

    Moderate-good reliability (κ = 0.65-0.78). The modified Ashworth scale will be used to determine the level of spasticity in the participants. The assessment is done by bringing the patient's limb to the possible maximal extension from flexion and then flexion to extension until the point of resistance is met. Scoring is done from 0-4 (0 being normal while 4 being rigid).

    Time frame: Baseline, 3rd week, 6th week

  2. Fugl-Meyer Assessment Upper Extremity (FMA-UE)

    It is a stroke-specific, performance-based outcome measure used to assess upper limb motor recovery following a stroke. The FMA-UE consists of 33 items evaluating reflex activity, voluntary movement within and out of synergy, wrist and hand function, and coordination/speed. Each item is scored on a 3-point ordinal scale (0 = cannot perform, 1 = performs partially, 2 = performs fully), with a maximum score of 66 indicating optimal motor function.

    Time frame: Baseline, 3rd week, 6th week

  3. Muscle Strength Manual Muscle Testing (MMT)

    A standardized, performance-based outcome measure assessing muscle strength on a 6-point ordinal scale (0 = no contraction to 5 = normal strength). Evaluates key upper limb muscle groups, including shoulder, elbow, forearm, wrist, and grip bilaterally. Requires no equipment, is clinically feasible, and provides immediate interpretable results. Excellent reliability (ICC = 0.84-0.92) in stroke.

    Time frame: Baseline, 3rd week, 6th week

  4. Goniometry

    Good-excellent reliability (ICC = 0.90-0.98). A goniometer will be used to assess the range of motion of all joints. A goniometer can assess both active and passive ROM.

    Time frame: Baseline, 3rd week, 6th week

07

Study locations

1 of 1 sites recruiting
  • Barkat Medical and Physical-Therapy Center Hazaratown Quetta
    Quetta, Balochistan, Pakistan
    Recruiting
08

References and documents

Publications

  • Shahid J, Kashif A, Shahid MK. A comprehensive review of physical therapy interventions for stroke rehabilitation: impairment-based approaches and functional goals. Brain Sciences. 2023;13(5):717. Sherin A, Ul-Haq Z, Fazid S, Shah BH, Khattak MI, Nabi F. Prevalence of stroke in Pakistan: Findings from Khyber Pakhtunkhwa integrated population health survey (KP-IPHS) 2016-17. Pakistan Journal of Medical Sciences. 2020;36(7):1435. Baker, R. T., Nasypany, A., Seegmiller, J. G., & Baker, J. G. (2023). Instrument-assisted soft tissue mobilization: A systematic review and meta-analysis of current literature. Journal of Athletic Training, 58(2), 112-125. Cheatham, S. W., Baker, R. T., & Abdenour, T. E. (2021). Instrument-assisted soft tissue mobilization: A clinical commentary. International Journal of Athletic Therapy and Training, 26(4), 187-193. Cuesta-Vargas, A. I., González-Sánchez, M., & Kuisma, R. (2022). Reliability of goniometric measurements in stroke patients: A systematic review. Disability and Rehabilitation, 44(8), 1342-1352. Grefkes, C., & Fink, G. R. (2020). Recovery from stroke: Current concepts and future perspectives. Neurological Research and Practice, 2(1), 17-29. Harb, A., & Kishner, S. (2023). Modified Ashworth Scale. In StatPearls. StatPearls Publishing.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Nov 2026, 4 months after the start.

Of 3,117 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 4 months is below that.

Counting every sponsor, half of 3,261 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2026
First posted
Nov 13, 2026
StartActual
Jul 9, 2026
Primary completionEst.
Nov 15, 2026
CompletionEst.
Nov 30, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937098
Lead sponsor
Ibadat International University, Islamabad
Responsible party
Sponsor
First posted
Nov 13, 2026
Start date
Jul 9, 2026
Primary completion
Nov 15, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Nov 13, 2026

Study contacts

Ghulam Mohiuddin Ghulam Mohiuddin, DPT, MS-PT NPT
Contact
ghulammohiuddinrind@gmail.com
+923323817426
Nazish Rafique Dr Nazish Rafique, DPT, MS-PT NMPT
Contact
nazish2312@gmail.com
03002132436
Nazish Rafique, DPT, MS-PT NMPT
study chair · Ibadat International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion